Brief: Carisma And Moderna Expand Collaboration To Develop Two In Vivo CAR-M Therapies For Autoimmune Diseases
Sept 10 (Reuters) - Carisma Therapeutics Inc CARM.O :
* CARISMA AND MODERNA EXPAND COLLABORATION TO DEVELOP TWO IN
VIVO
CAR-M THERAPIES FOR AUTOIMMUNE DISEASES
* CARISMA THERAPEUTICS INC - MODERNA NOMINATES TWO
AUTOIMMUNE
DISEASE TARGETS UNDER COLLABORATION
* CARISMA THERAPEUTICS INC - TO HANDLE DISCOVERY, MODERNA TO
LEAD
CLINICAL DEVELOPMENT
* CARISMA THERAPEUTICS INC - ELIGIBLE FOR MILESTONES AND
ROYALTY
PAYMENTS
Source text for Eikon: ID:nPn20304Xa
Further company coverage: CARM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Carisma Therapeutics
See all newsBrief: Carisma Therapeutics & Modernatx Amend Collaboration & And License Agreement - SEC Filing
Carisma Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Carisma Therapeutics Inc expected to post a loss of 9 cents a share - Earnings Preview
Brief: Carisma Therapeutics And Orthocellix Enter Into Definitive Merger Agreement
Carisma Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary